BIOMAT Database Logo BIOMAT Database Logo

Characterization of a plasma-derived double-viral-inactivated factor VIII concentrate (antihaemophilic factor [human]): Focus on TTP treatment. 2021

Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
Department of Research & Innovation, Kedrion S.p.A, Loc. Bolognana, Italy.

UI MeSH Term Description Entries
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006490 Hemostatics Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. Antihemorrhagic,Hemostatic,Antihemorrhagics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
Pharmacokinetics and acute tolerance of a double virus inactivated plasma derived factor VIII concentrate.
July 1999, Haemophilia : the official journal of the World Federation of Hemophilia,
Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate.
January 1997, Thrombosis and haemostasis,
Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
Hepatitis A viral safety of plasma-derived factor VIII concentrate Koate-HP.
January 1994, Vox sanguinis,
Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
Human plasma and plasma fractions as sources of factor VIII (antihaemophilic factor).
April 1969, Vox sanguinis,
Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
[In vitro characterization of human plasma fraction factor VIII concentrate].
April 1985, Die Pharmazie,
Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
A plasma-derived von Willebrand factor/factor VIII concentrate (Wilate).
June 2010, The Medical letter on drugs and therapeutics,
Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
Successful treatment of congenital TTP with a novel approach using plasma-derived factor VIII.
October 2013, Journal of pediatric hematology/oncology,
Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
Effect of factor VIII concentrate on leucocyte cytokine production: characterization of TGF-beta as an immunomodulatory component in plasma-derived factor VIII concentrate.
September 1999, British journal of haematology,
Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
Zero incidence of inhibitor development in previously treated haemophilia A, HIV-negative patients upon exposure to a plasma-derived high-purity and double viral inactivated factor VIII concentrate.
January 1998, Haemophilia : the official journal of the World Federation of Hemophilia,
Filippo Mori, and Ilaria Nardini, and Andrea Caricasole, and Novinyo Serge Amega, and Claudio Farina
Antihaemophilic factor (factor VIII) from human granulocytes.
January 1977, Haematologia,
Copied contents to your clipboard!